|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, 124 Sherman Hall, University at Buffalo, The State University of New York, Buffalo, NY 14214-3005, USA
C-type inactivation is present in many voltage-gated potassium channels and is probably related to slow inactivation in calcium and sodium channels. The mechanisms underlying C-type inactivation are unclear, but it is sensitive to mutations on both the extra- and intracellular sides of the channel. We used an N-terminal deleted channel with a valine to alanine point mutation at the intracellular side of S6 (fKv1.4[V561A]
N). This construct alters recovery from inactivation and inverts the relationship between C-type inactivation and [K+]o. We used this inverted relationship to examine C-type inactivation and coupling mechanisms between N- and C-type inactivation. The valine to alanine mutation reduces the channel's affinity for both quinidine and the N-terminal domain. However, binding of the N-terminal or quinidine restores normal recovery from inactivation. This suggests that coupling between N- and C-type inactivation is dominated by allosteric mechanisms. The permeation mechanism, driven by a reduction in permeant [K+]o following pore block (which would retard C-type inactivation), contributes minimally to coupling in these channels. We propose that the cytoplasmic half of S6 forms part of the N-terminal binding site, as previously predicted from X-ray crystallography studies in the distantly related KcsA channel. Binding of the N-terminal domain or a positively charged lipophilic compound such as quinidine interacts with the hydrophobic moieties on S6 in the bound state. This binding can orientate S6 into a conformation which resembles the normal C-type inactivated state. This is the probable mechanism by which drug or N-terminal binding increases the rate of C-type inactivation via an allosteric mechanism.
(Received 14 September 2003;
accepted after revision 24 October 2003;
first published online 7 November 2003)
Corresponding author R. L. Rasmusson: Department of Physiology and Biophysics, 124 Sherman Hall, State University of New York at Buffalo, Buffalo, NY 14214-3005, USA. Email: rr32{at}buffalo.edu
This article has been cited by other articles:
![]() |
J.-H. Lee, B.-H. Lee, S.-H. Choi, I.-S. Yoon, M. K. Pyo, T.-J. Shin, W.-S. Choi, Y. Lim, H. Rhim, K. H. Won, et al. Ginsenoside Rg3 Inhibits Human Kv1.4 Channel Currents by Interacting with the Lys531 Residue Mol. Pharmacol., March 1, 2008; 73(3): 619 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. L. Bett and R. L. Rasmusson Modification of K+ channel-drug interactions by ancillary subunits J. Physiol., February 15, 2008; 586(4): 929 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Skerritt and D. L. Campbell Role of S4 positively charged residues in the regulation of Kv4.3 inactivation and recovery Am J Physiol Cell Physiol, September 1, 2007; 293(3): C906 - C914. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. L. Bett, M. J. Morales, D. L. Beahm, M. E. Duffey, and R. L. Rasmusson Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel J. Physiol., November 1, 2006; 576(3): 755 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Patel and D. L. Campbell Transient outward potassium current, 'Ito', phenotypes in the mammalian left ventricle: underlying molecular, cellular and biophysical mechanisms J. Physiol., November 15, 2005; 569(1): 7 - 39. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |